S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 25 of 25

Issue Date	Title / Author(s) / Citation	File
2010-08	Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Bang, Yung-Jue; Van Cutsem, Eric; Feyereislova, Andrea; Chung, Hyun C.; Shen, Lin; Sawaki, Akira; Lordick, Florian; Ohtsu, Atsushi; Omuro, Yasushi; Satoh, Taroh; Aprile, Giuseppe; Kulikov, Evgeny; Hill, Julie; Lehle, Michaela; Ruschoff, Josef; Kang, Yoon-Koo The Lancet, Vol.376 No.9742, pp.687-697	DOI
2010-09	A phase I/II and pharmacogenomic study of pemetrexed and cisplatin in patients with unresectable, advanced gastric carcinoma Chen, Jen-Shi; Chao, Yee; Bang, Yung-Jue; Roca, Enrique; Chung, Hyun C.; Palazzo, Felipe; Kim, Yeul H.; Myrand, Scott P.; Mullaney, Brian P.; Shen, Li J.; Linn, Carlos Anti-Cancer Drugs, Vol.21 No.8, pp.777-784	DOI
2011-06	The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010 Van Cutsem, E.; Dicato, M.; Geva, R.; Arber, N.; Bang, Y.; Benson, A.; Cervantes, A.; Diaz-Rubio, E.; Ducreux, M.; Glynne-Jones, R.; Grothey, A.; Haller, D.; Haustermans, K.; Kerr, D.; Nordlinger, B.; Marshall, J.; Minsky, B. D.; Kang, Y. K.; Labianca, R.; Lordick, F.; Ohtsu, A.; Pavlidis, N.; Roth, A.; Rougier, P.; Schmoll, H. J.; Sobrero, A.; Tabernero, J.; Van de Velde, C.; Zalcberg, J. Annals of Oncology, Vol.22, pp.v1-v9	DOI
2011-06	Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis Hong, Junshik; Han, Sae-Won; Ham, Hye Seon; Kim, Tae-Yong; Choi, In Sil; Kim, Byung-Su; Oh, Do-Youn; Im, Seock-Ah; Kang, Gyeong Hoon; Bang, Yung-Jue; Kim, Tae-You Cancer Chemotherapy and Pharmacology, Vol.67 No.6, pp.1323-1331	DOI
2011-07	Prognostic implication of 18F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study Shin, Dong-Yeop; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Cancer Chemotherapy and Pharmacology, Vol.68 No.1, pp.165-175	DOI
2011-12	Capecitabine in gastric cancer Bang, Yung-Jue Expert Review of Anticancer Therapy, Vol.11 No.12, pp.1791-1806	DOI
2012-01	Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial Bang, Yung-Jue; Kim, Young-Woo; Yang, Han-Kwang; Chung, Hyun Cheol; Park, Young-Kyu; Lee, Kyung Hee; Lee, Keun-Wook; Kim, Yong Ho; Noh, Sang-Ik; Cho, Jae Yong; Mok, Young Jae; Kim, Yeul Hong; Ji, Jiafu; Yeh, Ta-Sen; Button, Peter; Sirzen, Florin; Noh, Sung Hoon The Lancet, Vol.379 No.9813, pp.315-321	DOI
2012-09	Advances in the Management of HER2-positive Advanced Gastric and Gastroesophageal Junction Cancer Bang, Yung-Jue Journal of Clinical Gastroenterology, Vol.46 No.8, pp.637-648	DOI
2013-11	Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis Paoletti, Xavier; Oba, Koji; Bang, Yung-Jue; Bleiberg, Harry; Boku, Narikazu; Bouche, Olivier; Catalano, Paul; Fuse, Nozomu; Michiels, Stefan; Moehler, Markus; Morita, Satoshi; Ohashi, Yasuo; Ohtsu, Atsushi; Roth, Arnaud; Rougier, Philippe; Sakamoto, Junichi; Sargent, Daniel; Sasako, Mitsuru; Shitara, Kohei; Thuss-Patience, Peter; Van Cutsem, Eric; Burzykowski, Tomasz; Buyse, Marc Journal of the National Cancer Institute, Vol.105 No.21, pp.1667-1670	DOI
2014-02	A Phase II Study of Bevacizumab, Oxaliplatin, and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer A Prospective, Multicenter Trial of the Korean Cancer Study Group Hong, Yong Sang; Lee, Sung Sook; Kim, Kyu-pyo; Lee, Jae-Lyun; Kang, Yoon-Koo; Shin, Sang Joon; Ahn, Joong Bae; Jung, Kyung Hae; Im, Seock-Ah; Kim, Tae-You; Kim, Jee Hyun; Park, Young Suk; Kim, Tae Won American Journal of Clinical Oncology, Vol.37 No.1, pp.19-23	DOI
2015-03	Treatment for unresectable gastric cancer Kim, Tae-Yong; Oh, Do-Youn; Bang, Yung-Jue 대한의사협회지, Vol.58 No.3, pp.209-215	DOI
2015-10	Phase I Study of Axitinib in Combination with Cisplatin and Capecitabine in Patients with Previously Untreated Advanced Gastric Cancer Oh, Do-Youn; Doi, Toshihiko; Shirao, Kuniaki; Lee, Keun-Wook; Park, Sook Ryun; Chen, Ying; Yang, Liqiang; Valota, Olga; Bang, Yung-Jue Cancer Research and Treatment, Vol.47 No.4, pp.687-696	DOI
2015-11	The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Bang, Ju-Hee; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn American Journal of Cancer Research, Vol.5 No.11, pp.3376-3388
2016-02	Lapatinib in combination with capecitabine plus oxaliplatin in human epidermal growth factor receptor 2-positive advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma: TRIO-013/LOGiC-A randomized phase III trial Hecht, J. Randolph; Bang, Yung-Jue; Qin, Shukui K.; Chung, Hyun C.; Xu, Jianming M.; Park, Joon O.; Jeziorski, Krzysztof; Shparyk, Yaroslav; Hoff, Paulo M.; Sobrero, Alberto; Salman, Pamela; Li, Jin; Protsenko, Svetlana A.; Wainberg, Zev A.; Buyse, Marc; Afenjar, Karen; Houe, Vincent; Garcia, Agathe; Kaneko, Tomomi; Huang, Yingjie; Khan-Wasti, Saba; Santillana, Sergio; Press, Michael F.; Slamon, Dennis Journal of Clinical Oncology, Vol.34 No.5, pp.443-451	DOI
2016-08	Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): A multinational placebo-controlled phase II Trial Pavlakis, Nick; Sjoquist, Katrin M.; Martin, Andrew J.; Tsobanis, Eric; Yip, Sonia; Kang, Yoon-Koo; Bang, Yung-Jue; Alcindor, Thierry; O'Callaghan, Christopher J.; Burnell, Margot J.; Tebbutt, Niall C.; Rha, Sun Young; Lee, Jeeyun; Cho, Jae-Yong; Lipton, Lara R.; Wong, Mark; Strickland, Andrew; Kim, Jin Won; Zalcberg, John R.; Simes, John; Goldstein, David Journal of Clinical Oncology, Vol.34 No.23, pp.2728-2728	DOI
2016-11	TTP as a surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: meta-analysis of randomised controlled trials Lee, Dae-Won; Jang, Myoung-Jin; Lee, Kyung-Hun; Cho, Eun Ju; Lee, Jeong-Hoon; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You British Journal of Cancer, Vol.115 No.10, pp.1201-1205	DOI
2017-02	The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis Chan, David L.; Sjoquist, Katrin M.; Goldstein, David; Price, Timothy J.; Martin, Andrew J.; Bang, Yung-Jue; Kang, Yoon-Koo; Pavlakis, Nick PLoS ONE, Vol.12 No.2, p. e0172307	DOI
2017-02	A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) Kim, Hye Ryun; Jang, Joung Soon; Sun, Jong-Mu; Ahn, Myung-Ju; Kim, Dong-Wan; Jung, Inkyung; Lee, Ki Hyeong; Kim, Joo-Hang; Lee, Dae Ho; Kim, Sang-We; Cho, Byoung Chul Oncotarget, Vol.8 No.9, pp.15943-15951	view file DOI
2017-10	Efficacy of sequential ipilimumab monotherapy versus best supportive care for unresectable locally advanced/metastatic gastric or gastroesophageal junction cancer Bang, Yung-Jue; Cho, Jae Yong; Kim, Yeul Hong; Kim, Jin Won; Di Bartolomeo, Maria; Ajani, Jaffer A.; Yamaguchi, Kensei; Balogh, Agnes; Sanchez, Teresa; Moehler, Markus Clinical Cancer Research, Vol.23 No.19, pp.5671-5678	DOI
2018-03	A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma Lee, Dae-Won; Lee, Kyung-Hun; Kim, Hee-Jun; Kim, Tae-Yong; Kim, Jin-Soo; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Im, Seock-Ah; Kim, Tae-You BMC Cancer, Vol.18 No.1, p. 252	DOI
2018-05	Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives Taieb, Julien; Moehler, Markus; Boku, Narikazu; Ajani, Jaffer A.; Ruiz, Eduardo Yanez; Ryu, Min-Hee; Guenther, Silke; Chand, Vikram; Bang, Yung-Jue Cancer Treatment Reviews, Vol.66, pp.104-113	DOI
2018-06	Safety and antitumor activity of pembrolizumab in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer Rugo, Hope S.; Delord, Jean-Pierre; Im, Seock-Ah; Ott, Patrick A.; Piha-Paul, Sarina A.; Bedard, Philippe L.; Sachdev, Jasgit; Le Tourneau, Christophe; van Brummelen, Emilie M. J.; Varga, Andrea; Salgado, Roberto; Loi, Sherene; Saraf, Sanatan; Pietrangelo, Dina; Karantza, Vassiliki; Tan, Antoinette R. Clinical Cancer Research, Vol.24 No.12, pp.2804-2811	DOI
2019-02	A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer Bang, Y. -J.; Kang, Y. -K.; Ng, M.; Chung, H. C.; Wainberg, Z. A.; Gendreau, S.; Chan, W. Y.; Xu, N.; Maslyar, D.; Meng, R.; Chau, I; Ajani, J. A. European Journal of Cancer, Vol.108, pp.17-24	DOI
2021	DNA Damage Repair Inhibitor for Breast Cancer Treatment Min, Ahrum; Lee, Kyung-Hun; Im, Seock-Ah Advances in Experimental Medicine and Biology, Vol.1187, pp.159-179	DOI
2023-06	Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer Im, S.-A.; Gennari, A.; Park, Y.H.; Kim, J.H.; Jiang, Z.-F.; Gupta, S.; Fadjari, T.H.; Tamura, K.; Mastura, M.Y.; Abesamis-Tiambeng, M.L.T.; Lim, E.H.; Lin, C.-H.; Sookprasert, A.; Parinyanitikul, N.; Tseng, L.-M.; Lee, S.-C.; Caguioa, P.; Singh, M.; Naito, Y.; Hukom, R.A.; Smruti, B.K.; Wang, S.-S.; Kim, S.B.; Lee, K.-H.; Ahn, H.K.; Peters, S.; Kim, T.W.; Yoshino, T.; Pentheroudakis, G.; Curigliano, G.; Harbeck, N. Esmo Open, Vol.8 No.3, p. 101541	DOI